Fig. 2

(A). Blood levels of NK cells in relationship to the rate of disease progression in ALS, as measured by ΔFS. Data are expressed as median with IQR. p, Kruskal-Wallis One-Way ANOVA on Ranks. (B). Histogram showing the levels of the NK cells in ALS patients according to the estimated rate of progression (ΔFS): slow [≤ 0.5]; intermediate [> 0.5 - ≤ 1.0]; rapid [> 1.0]